Moret, F.; Menilli, L.; Battan, M.; Tedesco, D.; Columbaro, M.; Guerrini, A.; Avancini, G.; Ferroni, C.; Varchi, G.
Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy. Pharmaceutics 2021, 13, 1130.
https://doi.org/10.3390/pharmaceutics13081130
AMA Style
Moret F, Menilli L, Battan M, Tedesco D, Columbaro M, Guerrini A, Avancini G, Ferroni C, Varchi G.
Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy. Pharmaceutics. 2021; 13(8):1130.
https://doi.org/10.3390/pharmaceutics13081130
Chicago/Turabian Style
Moret, Francesca, Luca Menilli, Manuele Battan, Daniele Tedesco, Marta Columbaro, Andrea Guerrini, Greta Avancini, Claudia Ferroni, and Greta Varchi.
2021. "Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy" Pharmaceutics 13, no. 8: 1130.
https://doi.org/10.3390/pharmaceutics13081130
APA Style
Moret, F., Menilli, L., Battan, M., Tedesco, D., Columbaro, M., Guerrini, A., Avancini, G., Ferroni, C., & Varchi, G.
(2021). Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy. Pharmaceutics, 13(8), 1130.
https://doi.org/10.3390/pharmaceutics13081130